Penserra Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,509
Closed -$11K 1001
2022
Q2
$11K Sell
2,509
-810
-24% -$5.85K ﹤0.01% 1223
2022
Q1
$28K Buy
3,319
+166
+5% +$1.17K ﹤0.01% 1157
2021
Q4
$27K Sell
3,153
-1,942
-38% -$18.5K ﹤0.01% 1182
2021
Q3
$52K Sell
5,095
-4,210
-45% -$36.8K ﹤0.01% 1040
2021
Q2
$97K Sell
9,305
-1,584
-15% -$15.6K ﹤0.01% 800
2021
Q1
$112K Buy
+10,889
New +$151K ﹤0.01% 670

Other funds holding SRTA

Penserra Capital Management's SRTA Position: Q3 2022 in Review

Penserra Capital Management sold out of Strata Critical Medical Inc (SRTA) in Q3 2022, closing a stake of 2,509 shares — an estimated $11K sold.

Penserra Capital Management first reported a position in SRTA in Q1 2021 and held it in 6 quarters. The position peaked at $112K in Q1 2021. 99 funds tracked by Wall St. Rank hold SRTA as of Q3 2022.

  • Penserra Capital Management reported no remaining Strata Critical Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Penserra Capital Management sold 2,509 Strata Critical Medical Inc shares in Q3 2022, an estimated $11K.
  • Penserra Capital Management first reported a position in Strata Critical Medical Inc in Q1 2021 and held it in 6 quarters.
  • Penserra Capital Management's Strata Critical Medical Inc position peaked at $112K in Q1 2021.
  • 99 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.